#next generation sequencing data analysis

[pathologylab]

#G2M brings you the newly launched, highly #automated & user friendly software and workstation which can ensure a streamlined and effortless #NGS library preparation. The workstation can construct 24 libraries in one run over a short span of time, thus providing you with a good library preparation experience.

Contact us at social@genes2me.com or +91 8800821778 to know more about this revolutionary NGS #solution.

#nextgenerationsequencing #bioinformatics #genomics #ngspanels #panels #analysis #software #sequencing #research #liquidbiopsy #ngsanalysis #genomics #biotech #biotechnology #bioinformatics #yearsofexcellence #data #bioindia #dna #rna #genetics #liquidbiopsy #sequencing #genome #genomeanalysis #molecularbiology #genes2me

[sharieb]

Held in the Hollowed Fragments 5: To Sleep is to Return

Synopsis: Haunted by a persistent ache and fragmented memories, he finds solace only within the realm of dreams, a fog-shrouded sanctuary where a mysterious woman, both familiar and real, awaits him. What begins as a quest to understand these nightly visions transforms into a profound emotional awakening. Through shared moments of quiet intimacy and gentle touch, he reconnects with a lost part of himself, surrendering control and embracing vulnerability. She is no longer a distant ideal but a living presence who teaches him to create, to rest, and to feel deeply. Pairing: LADs x Non! Mc (you)

LADs POV (General and Individual) Genres: Fluff and Hurt/ (some) comfort

Word count: +3.1K

Content Warning: Fluff, hurt with some comfort, fixation, obsession, feelings of loss and grief, hints of identity struggle, implied substance use, emotional dependency, subtle hints of control issues

Music: Youth by Daughter

Taglist: @plzdonutpercieveme, @miuangel, @xiisblogs

First Previous Next

Why wasn’t she here?

The thought beats behind his temples like a quiet pulse—soft, relentless. Ever since that last dream—the one where he saw himself, the boy he used to be, and her, wrapped in something tender and untouchable—he hasn’t been able to let it go.

She was there for him. She stayed. Through every storm. Every silence. Every unraveling of the world around them.

But where is she now?

And why can’t he remember losing her?

The waking world gives no answers. Only the ache remains—dull, insistent. So he does the only thing that feels right:

He returns to the fog.

Night after night, he slips beneath the surface, welcoming the chill of mist and memory. What was once an occasional dream becomes a ritual. The fog thickens faster. Greets him like an old friend—quiet, constant.

And she is always there.

At first, she’s a presence. Familiar, but blurred. Her voice was a soft echo. Her laugh was a thread of warmth pulled from some half-remembered time. He treats it like a puzzle. Logs the fragments. Tracks lunar phases. Journals dream symbols, sleep cycles, anything that might explain her. As if he's a scientist hunting for reason.

But then, one night—

She sharpens.

No more silhouettes. No more teasing shadows.

He sees her face—truly sees it.

Not some sculpted ideal. Not the distant, porcelain perfection of fantasy. No, her beauty is grounded. Gentle. Real. A mouth that lifts a little crooked when she laughs. A nose that crinkles. Soft eyes full of clarity and storm. There’s nothing flawless about her—and that’s what makes her unforgettable. She doesn’t feel imagined. She feels inevitable.

She smiles, and the world softens as she tells him her name.

She says his name, and something inside him answers.

And for the first time, he stops watching from a distance. He steps forward.

He is no longer the echo of a past self. No longer just a dreamer looking in.

He is present. Awake inside the dream.

And the dream changes.

It started with replays of long-forgotten memories, core memories from a different life that had somehow ingrained and shaped his current lifetime. Soon, new dreams were made by them. New moments. New warmth. They walk shoulder to shoulder through fogged ruins and half-lit skies. She leans into him on a crumbling ledge above some forgotten city. He threads his fingers through hers. She hums a lullaby that curls through the fog like smoke.

She touches his face.

He touches hers.

It feels terrifyingly real. And impossibly safe.

He tells himself it’s still about understanding. About answers. But he knows now—

He’s fallen.

And the fog, once a mystery, has become a home.

It begins with the desire for data.

He records sleep cycles. Notes variations in REM duration. Tags dream sequences in coded shorthand. Anything to quantify what keeps pulling him under. The dreams aren't random—he’s certain of it. And if there’s a pattern, he’ll find it.

But analysis gives way to fixation.

The fog becomes a constant. The woman in it—no longer an anomaly, but a presence he anticipates. Her voice lingers past waking. Her silhouette stays imprinted behind his eyelids, more persistent than memory. He tells himself he's looking for causality, perhaps even a misfiring of neurons tied to fatigue or unprocessed emotion.

But he knows better.

The obsession has taken root.

He no longer observes. He yearns. For the dreams. For her. For the strange, impossible feeling that he was once whole in a way the real world no longer allows.

And then, the ache turns sweet.

One dream slips in quieter than the others. It isn’t grand or tragic. Just her—offering him something small. A piece of candy, unwrapped and pressed into his palm like a secret.

He eyes it suspiciously at first, turns it over with a stoic detachment. But she only grins, patient and expectant. So he places it on his tongue—and freezes.

His whole face scrunches. Eyebrows shoot up. A tiny sound escapes him, a cross between surprise and wonder. It’s sweet. Unreasonably sweet. His eyes widen like he’s just discovered a new vital sign. Then comes a quiet, pleased hum. He tries to hide how much he likes it. Fails. Completely.

She laughs—not at him, but because of him. Because in that small moment, he lets his guard down. And he smiles. An open, boyish thing not seen in years.

After that, he begins to crave the dreams. Not just for what they show him—but for the comfort she brings. The ease of her presence. A place where nothing is demanded of him beyond simply existing.

He remembers another dream: gentler, still. She doesn’t flinch at the frost in his hands or the cold breath curling around his words.

Instead, she drew close and took his cold hands in hers, into her warmth. Then she asked, “Can you make something beautiful with it?”

That night, he tries.

The first creation is a mess of soft snow—a clumsy little thing that looks vaguely like a rabbit, or perhaps a bear. It melts before he can finish. But she takes it in her hands like it’s something precious. Her laughter doesn’t mock. It invites.

So, he tries again.

The next one isn’t perfect. Still awkward, still too blocky—but it doesn’t melt. And when she sees it, her eyes light up.

For the first time, his power doesn’t feel like a burden. It feels like something he chose. Something soft and expressive, shaped by her belief in him.

With her, even winter begins to feel warm.

At first, the dreams seem like nothing more than a warm feeling.

A quiet space. A breath between days. No urgency. No threat. Just fog curling around the edges of his mind like a soft blanket.

Then she appears.

Not with grandeur. Not like a storm or spark—but like morning light through curtains. Familiar. Gentle. Steady.

In the fog, she smiles with a softness that dissolves fear. Her hand finds his, and his walls fall like stardust. He stops waiting for dreams—he begins living for them.

Time becomes elastic. Reality dims. He speaks less. Sleeps more. Every silence in the fog hums with her understanding. She sees through him—every hesitation, every mask. And with her, he’s not just known.

He is safe.

And he’ll trade anything for that.

He dreams of the first time she took his hand and guided it along ivory keys.

He’d never touched a piano before—not properly. It had always seemed like something unreachable, like art for someone else’s world. But her presence stripped away the pressure. There was no lesson. No expectation. Just play. She sat beside him, shoulder against his, and whispered the first few notes like a secret.

They played for hours.

He didn’t want to stop.

The sound stayed with him even after waking—notes lingering in his bones like lullabies half-remembered.

Another memory forms in the fog: a lazy afternoon by still water.

She teaches him how to cast fishing lines. There’s no rush. No need to catch anything. It’s about stillness. About waiting. About learning to listen.

They talk about nothing and everything. She teases him—gently, sweetly. And he loves it. He can be soft with her. He can lean. He doesn’t have to explain why some days feel heavier than others. She just… gets it.

And gods, he loves to sleep after she showed him the enjoyment in sleeping. Naps become a shared secret—a quiet joy between them. He finds himself loving them just as much as she does.

Sometimes she teaches him how to fight with a sword—playful sparring matches where laughter rings louder than any clash of blades. Their movements become a dance of trust and discovery, blending strength and softness in a way that feels anything but ordinary.

When he plays piano now—on sleepless nights, in quiet corners of his life—it’s for her.

When he closes his eyes midday, letting the fog claim him early, it’s to find her.

And when he’s too tired to speak, when the world gets loud and sharp and cruel—he thinks of her smile, her teasing, the way she made every shared silence feel like love.

He doesn’t chase the dream anymore.

He surrenders to it.

He doesn’t remember when the dreams began.

Not exactly.

They come softly, like brushstrokes on canvas—layered until one day, he wakes with colours lingering in his lungs. Fingers tingling like they’ve been holding a paintbrush all night.

At first, it’s only texture. Fog and light and the ghost of melody. But then comes colour. Explosive, radiant colour that bleeds into everything. Walls, sky, even the spaces between his ribs. He sees her there, always at the centre of it. Not directing the dream, not standing still like a muse, but moving. Dancing. Laughing. Living inside the very chaos that calls to him.

And the world she moves through?

It’s like stepping into a living canvas.

A broken theatre, scattered with forgotten props. Rusted catwalks high above a city that hums with unfinished lullabies. Neon lights flickering in time with her breath. It's surreal. Beautiful. A little ridiculous. Like a dream designed by someone who never learned to colour inside the lines—and never cared to try.

The fog gives way to memory.

Once, when he was younger—loud, defiant, always on the edge of trouble—she stopped him mid-mischief with nothing more than a soft voice and a brush. “Try this instead,” she said, and handed him a jar of watercolours.

He scoffed.

Then, he tried.

And in those colours, something inside him stilled for the first time. Not silenced, but understood.

He kept returning to her.

In another memory, older now, she pulled him from a suffocating routine and took him wandering through open spaces—mountains, ruined galleries, flowering alleyways at twilight. “Look,” she whispered, and pointed to the way light pooled across stone, to the cracks in murals, to the laughter of strangers. “Art is everywhere.”

With her, he saw the world differently. He saw himself differently.

Back in the dreams, she takes his hand and twirls him across cracked tiles, dares him to stop thinking.

He doesn’t.

He lets go.

There’s a moment—just one—where she hands him a brush. No instruction. No expectation. Just… trust.

And so, he paints.

It isn’t good. The lines are messy, the colour runs too fast, and the proportions are all wrong. But she looks at it like it’s the first sunrise after a hundred storms.

He paints again.

The next one flows more easily. His hands know the rhythm. His heart keeps the beat. The fog itself seems to pulse with colour now, blooming with every flick of his wrist.

In the waking world, he hasn’t touched a canvas in weeks. Maybe months. The passion faded. The spark flickered. There were days when even picking up a pencil felt like a lie.

But in this dream—with her—creation feels effortless. Not performative. Not judged.

Just alive.

She tells him, one night, as they lie in a room of floating murals, that art doesn’t need to be perfect to be sacred. That sometimes beauty is born in the act of trying.

He doesn’t answer.

He just watches the way her fingertips glow as she traces stars into the dark.

And something in him stirs.

A quiet, long-lost hunger—not just for her, but for the joy he’d buried beneath expectations and deadlines.

In the dream scape, he creates without fear. Without self-loathing.

With her, he remembers why he ever started.

He begins to recreate her.

On paper. In paint. In quiet songs, he hums without realising. Her silhouette becomes muscle memory. The fog coils around her like brushstrokes. He calls her his muse, but what he’s building is more than memory.

It’s a sanctuary.

He forgets work. Misses meals. Cancels plans. Nothing else matters. She becomes beauty itself—singular, sacred. Even her flaws are beloved, though they blur at the edges. She is not a substitute.

She is everything.

And he remembers She once gave him a brush, guided his hand through colour, taught him that mess could be beauty and silence could be art. His fingers have never stopped painting. Not even when he forgets why. The memory lingers beneath his nails like pigment, like colour blooming in grey.

He doesn’t fall. He chooses.

Or so he says.

The fog is now his dominion. In the waking world, he commands rooms, bends rules, and carves order from chaos. But here, in the mist, control isn't demanded—it dissolves. And still, he tells himself he is the one chasing. That he is in control of the descent.

But the signs say otherwise.

He changes his sleep schedule. Switches tea blends. Test supplements. Anything to quicken the fog’s arrival. The dreams have become more than refuge—they are a necessity. And she, the woman wrapped in mist and memory, waits with hands that never judge and eyes that see too deeply.

With her, he finds the one thing power has never given him.

Rest.

At first, it’s silent between them. Comfortable. Wordless.

But then one night, the fog offers sound.

Not speech—music. Strange and nostalgic, like a song half-heard through a wall. She leads him by the hand to where instruments wait in the haze. Keys. Strings. Pipes. They’re unfamiliar. He’s never been good with them. Never been good with sound.

But she is.

She teaches with laughter, not pressure. Every wrong note earns a smile. Every fumbling chord becomes a shared secret. Her fingers guide his over organ keys, and his hands remember what his mind does not. She hums, and somehow, impossibly, their mismatched voices blend. She makes even his tone-deaf efforts feel like something worth hearing.

He doesn’t remember learning to sing. Not really. But he remembers her.

He remembers the way she made music feel like home.

Later dreams shift, carrying the scent of dust and vinyl. She slips an old record into his hand, eyes twinkling. The fog stretches, transforms into a glowing ballroom of their own making. Music crackles to life. Strings swell. She doesn’t wait for grace or rhythm. She just pulls him in.

They dance.

He stumbles. She laughs. Her joy becomes the rhythm.

She spins him beneath phantom chandeliers, teaches him to listen to the beat beneath chaos, to find the melody tucked inside silence. When she draws him to the organ once more, her hands overlap his—steady, warm, unwavering. The chords swell, and the music becomes something more than sound. It becomes memory. Connection. Surrender.

He wakes, sometimes, with the ghost of harmony still in his fingertips.

He plays nothing perfectly. He sings with no training. But now, in the depths of the night—when others might sleep, but his world is wide awake, lawless and lit by neon—he finds silence between sounds. He puts on that same record—an old one he tracked down obsessively, heart pounding—and hums along to the notes they once made together in the dream.

He knows she’s not real.

And yet, in every bar of music, in every off-key note he dares to sing alone, she lives.

In the quiet hours, guilt settles in.

He tells himself he shouldn’t need her this much. That the fog is not for the living. That there are things to do, roles to maintain, people who count on him.

But none of that exists in the dream.

In the fog, there are no titles. No mistakes. No expectations. Just the hush between heartbeats, and the feel of her breath against his—steady, present, anchoring him when he’s drifting too far.

Here, he’s not falling apart.

He’s just… held.

He stays in bed longer. Forgets the days. Lets calls go unanswered. Responsibilities gather like dust in corners he can’t face. He knows he's breaking—but he hides it well.

And when he sleeps, she’s there to hold the pieces.

One night, the fog brings warmth, not from passion, but from the kitchen.

She’s laughing as he burns the rice, smoke curling up like incense. There’s a rhythm in the way she stirs the pot, a song in the sizzle and crackle of oil. The kitchen becomes a kind of sanctuary. Cluttered. Lived-in. Intimate.

He doesn’t remember learning to cook. But he remembers how she made it feel like love.

Every spill, every ruined dish became a shared story. A memory stitched into the quiet moments between them. The burnt rice becomes a symbol—not of failure, but of comfort. Of being seen in his imperfection and still being treasured.

He remembers the way she pointed to the sky one night, eyes full of stars, and told him to chase it. Told him he could.

He loved planes before he understood why.

But in the dream, it’s clear.

He loved them because she made him believe he could fly.

That he was brave enough. Strong enough.

Because once, in the fragile hours between fear and morning, she had been the one to shield him. To tell him he was more than the weight he carried. That being soft didn’t mean being weak. That courage wasn’t loud—it was the choice to rise again, even when broken.

She had protected him first.

And in doing so, taught him how to protect others.

He wakes with the scent of burnt rice still clinging to him, with phantom warmth pressed to his back and the echo of her voice in his ears.

He forgets the dream by midday.

But when he sees the sky—open, endless, waiting—he always looks up.

And then, one night—

She’s not beside him.

The fog curls differently. The dream doesn’t offer warmth, but memory.

Something old. Familiar.

But something’s wrong.

She hesitates.

Smiles bloom. Laughter echoes. But there’s a flicker in her eyes, a tremble in her hands, a pause before she reaches for him.

His past self doesn’t notice.

But he does.

And the ache returns, sharper than before.

He’s no longer part of the moment. No longer the one she turns to. He has returned to being a spectator—watching through the veil as something sacred slips away. Watching as the moment tilts, as the intimacy falters, as she begins to fade.

This was the beginning. The first slip. The moment she started to disappear.

And he hadn't seen it.

Until now.

The fog has never lied. Not truly. It gave him comfort. Connection. Her.

But now it offers something else:

Truth.

Bit by bit.

She was there. She loved them. And then—something changed.

The question lingers like smoke in his lungs:

Why did she leave?

And why did they let her?

The fog returns, soft but sad.

The comfort remains. But so does the wound. Because something is coming.

And this time, he can’t afford to look away.

Writer's note: Oh my goodness! Thank you all so much for your support throughout this series. I'm still very (happily) overwhelmed but your replies, likes and feedback. I really never saw myself ever having a very accomplished little story, much less a series, but everyone's love and support truly motivates me to continue. So, thank you all once again for your support. I'm very grateful.

[covid-safer-hotties]

Emerging SARS-CoV-2 Resistance After Antiviral Treatment - Published Sept 26, 2024

Key Points Question Is there an increased frequency of SARS-CoV-2 antiviral resistance in individuals receiving antiviral therapy?

Findings In this cohort study with 156 participants, nirmatrelvir resistance mutations were detected more often in individuals who were treated with nirmatrelvir, especially those who were immunosuppressed, compared with untreated individuals. However, all mutations were present at relatively low frequencies, appeared transiently, and were unlikely contributors to instances of virologic rebound.

Meaning In this study, the emergence of SARS-CoV-2 strains with resistance to nirmatrelvir after treatment was rare, irrespective of virologic rebound.

Abstract Importance Previous studies have identified mutations in SARS-CoV-2 strains that confer resistance to nirmatrelvir, yet how often this resistance arises and its association with posttreatment virologic rebound is not well understood.

Objective To examine the prevalence of emergent antiviral resistance after nirmatrelvir treatment and its association with virologic rebound.

Design, Setting, and Participants This cohort study enrolled outpatient adults with acute COVID-19 infection from May 2021 to October 2023. Participants were divided into those who received antiviral therapy and those who did not. The study was conducted at a multicenter health care system in Boston, Massachusetts.

Exposure Treatment regimen, including none, nirmatrelvir, and remdesivir.

Main Outcomes and Measures The primary outcome was emergent SARS-CoV-2 antiviral resistance, defined as the detection of antiviral resistance mutations, which were not present at baseline, were previously associated with decreased antiviral efficacy, and emerged during or after completion of a participant’s treatment. Next-generation sequencing was used to detect low frequency mutations down to 1% of the total viral population.

Results Overall, 156 participants (114 female [73.1%]; median [IQR] age, 56 [38-69] years) were included. Compared with 63 untreated individuals, the 79 who received nirmatrelvir were older and more commonly immunosuppressed. After sequencing viral RNA from participants’ anterior nasal swabs, nirmatrelvir resistance mutations were detected in 9 individuals who received nirmatrelvir (11.4%) compared with 2 of those who did not (3.2%) (P = .09). Among the individuals treated with nirmatrelvir, those who were immunosuppressed had the highest frequency of resistance emergence (5 of 22 [22.7%]), significantly greater than untreated individuals (2 of 63 [3.1%]) (P = .01). Similar rates of nirmatrelvir resistance were found in those who had virologic rebound (3 of 23 [13.0%]) vs those who did not (6 of 56 [10.7%]) (P = .86). Most of these mutations (10 of 11 [90.9%]) were detected at low frequencies (<20% of viral population) and reverted to the wild type at subsequent time points. Emerging remdesivir resistance mutations were only detected in immunosuppressed individuals (2 of 14 [14.3%]) but were similarly low frequency and transient. Global Initiative on Sharing All Influenza Data analysis showed no evidence of increased nirmatrelvir resistance in the United States after the authorization of nirmatrelvir.

Conclusions and Relevance In this cohort study of 156 participants, treatment-emergent nirmatrelvir resistance mutations were commonly detected, especially in individuals who were immunosuppressed. However, these mutations were generally present at low frequencies and were transient in nature, suggesting a low risk for the spread of nirmatrelvir resistance in the community with the current variants and drug usage patterns.

[geneubi]

CRISPR screening libraries are powerful tools for high-throughput gene function research. Ubigene offers comprehensive CRISPR screening services, from library construction to data analysis. Our services include:

CRISPR-iScreen™ Technology: A proprietary platform for efficient CRISPR screening with high coverage and uniformity.

Library Plasmid Preparation: Amplification and validation of CRISPR library plasmids.

Custom CRISPR Library: Design and construction of tailored CRISPR libraries.

Library Virus Packaging: High-titer lentivirus production for library transduction.

Cell Pool Construction: Establishment of stable cell pools for screening.

Functional Screening and NGS Analysis: Execution of screening experiments and next-generation sequencing analysis.

Ubigene has 35+ ready-to-use libraries and provides one-stop services for your CRISPR screening needs. Explore our offerings and learn how we can accelerate your research by the link!

[my-jokes-are-my-armour]

I know I said that the "blorblos from the attic" won't be a thing but I just like to work with characters and analyse them. Therefore I will continue my journey on the "Star Trek characters ace people like" thing with Data this time.

Funnily, I don't think this will be the character I will have the most to say about this particular subject because there is almost nothing mirroring sexuality and romance in his development. It is not absent at all but this is just one point in many others. Maybe that's a part of why I liked him so much at the time. I was never found of the romantic affairs in series when they were too plot driven for a characters, because the conclusion is often the same : they overcome the difficulties and the reward is too often : kiss, bed, flesh. And I don't find it rewarding personally.

I don't mind when it happens, but keep it short and I will be fine. Make it long and I will began to feel like it is voyeurism. I don't mind romance and exploration of feelings in general - Data is more of this second part and the rare flesh moments are not "satisfying" for the character either. In that my little ace self can relate.

Note : I haven't seen Picard' series so my analysis doesn't cover eventual new interactions Data could have made after the older series.

Who is Data ?

Data is an android - basically a machine - kinda one of his kind. In reality there are more than one but they are all different. He was built and deprived of all emotions by design - another model with emotions programs went wrong - and Data is seeking to become more and more human.

In that he has a sort of Pinocchio syndrome.

At first I thought he was a substitute for a Spock like character. And he can be in several aspect : no emotions displayed, super strong and resistant compare to human, highly intelligent, used sometimes to mirror humanity contradictions in storytelling.

In a way he was but the development was different, and I enjoyed his journey. Spock had to deal with emotions. He was suppressing them. Data isn't. He cannot feel by design, and to the contrary of the vulcan, he wants to reach that.

He is making experience in every field he can imagine to understand how human work and emulate it, until he can feel. And the thing is, he is never discouraged by a failure, he is never tired of trying, because those are feelings he cannot have. So he is persevering tirelessly.

Sometimes those experiences lead to profond discussions, and put words on our own feelings or perceptions, but sometimes this is just cute.

I have to make a little side note here. Data is an interesting character with a very slow development towards his goal, but Brent Spiner who plays him, is fantastic. For various reasons, he had to play various characters in the show, sometimes alone facing himself, and it gives you his range, but what makes him Data is that weird uncanny valley he can pull out from nowhere.

Data is not unexpressive and will often display some accurate facial experessions in diverse situations. Basically, he will do in social interactions that need it. But this is also something that builds up with time, as he learns more about those interactions. In other case he can be unexpressive or emulate. And there are also his little head mouvements he does when Data computes that help bringing his not human nature. It looks like bird mouvements. There are many ways he brings that uncanny valley with him. The contrast can be disturbing and yet be funny sometimes, like here :

And that little extract will lead me you my next point. Because you can see in this sequence, Data is trying to learn to dance (for a wedding). There is absolutely nothing sexual involved with Beverly. She is friendly trying to help him. But in the final sequence, we can see him asking for a female dancer to practice and the computer generate a woman in a sexy outfit and sexy demeanours toward him, but Data doesn't care, he is here to learn to dance. He is not aroused by this woman as the show leads us to thing that it could be his reaction. Yes he is awkward then, but in all honesty, this has nothing to do with any sexual tension, and I find it very interesting that the point is elsewhere.

Data, sexuality and "feelings"

His journey is quite long and bumpy but very interesting, as he tries to integrate as much as he can of human behaviours. Sometimes, he would ask question to define things, like a child who is exploring is own self. The exploration of sentimentality, romance, liaisons etc comes like drops in the ocean of his questions about humans.

The sexual subjects are almost never in the equation of Data's humanity's quest.

For the sexual part, he is programmed to satisfy the sexual needs of an humanoid so he doesn't have to learn the technicalities, so to speak. What he lacks is the capacity to feel something for someone emotionally. He treats romance and everything that turns around it, like another social experiment.

It happens sometimes that someone is attracted to him and he is kissed. But he doesn't understand much of it.

At some point though, he formulates the wish to get involved in a relationship or to "procreate". That doesn't work very well each time, and the interesting things is that he allows us (viewers) to project feelings over something he doesn't feel at the time. The breakup. The loss of a child. Yet he expresses those things in his own ways. And his ways helps finding ours.

The case Jenna D'Sora

Data's issues about love and sexuality reside in lack of all emotions, not in specific triggers or any definitions of what that could represents for him, but some of his responses or interactions hit close to what I experience as an ace. While I do feel and am not responding as detached as he is, the awkwardness is the same. The conclusion of the story dedicated to that part of his development is failure, because the human counterpart didn't feel loved despite what he can offer. He accepts the failure as : "this is as far as I can get, this is beyond my grasp". Yep... Me too.

But the thing is, even if he wants to model his life into the social role humans display in majority, he never achieved that and he is well.

More interestingly, when he has finally a ship with programs to develop and explore emotions, he is not searching particularly for love. He has friendships he cherishes - especially with Geordy, Picard and Worf - who I will speak about later.

Despite his limitations, he understands the concept of love and the human need to seek for that. He is just not capable of such thing. He was also aware that his limitations would probably causing his partner emotional pain, which happens in the end, but she was aware of it too - they discussed it beforehand.

This relation is a total failure, yet, we can't say Data isn't capable of loving. He can't reprocicate the feeling but he shows some strong attachments.

The case Tasha Yar

I cannot speak about feelings, romance and everything for Data without mentioning her.

Very early on, on the show, they have a sexual affair. Tasha is like intoxicated when it happens and she doesn't want it to be something, so she made it clear to him when everything is back to normal. They had a normal working relationship after that. She dies later in the season.

Despite being asked to ignore what happened between them, for Data she was important. He always kept an holographic picture of her.

She is a precious memory of him and we will never know why and how it works for him. But she reappears sometimes like a reminder that : yes Data loved someone.

The case Spot

Yes Spot is Data's cat and no there is no sexual things here 😅. With him, he will have the same response we have to our pets. In a way, he empathised more with that cat in an organic way than with any other humanoids, while he didn't have his emotion ship.

He cares for him a lot, to the point that with his ship activated, he will cry of joy discovering him alive in the wreckage of the Enterprise after they crashed.

The Borg queen

The Borg queen might be the only one he felt attraction to. She goes dirty on him to gain his loyalty, offering him real skin and overloading him with new sensations while she blocked his emotions programs activated.

His desire for emotions is Data's weakness but he adapts quite quickly to a lot of it. Probably because he worked so hard before hand to understand things without being able to feel.

But Data's loyalty cannot be altered that easily when he experienced this kind of manipulation before, and he played the fool until he had the possibility to destroy the queen. He would tell Picard afterwrds that he was considering to accept her offer for 0.68 second, which is very long for him 😅.

Now this is about as far as it get in his exploration of love. What he will develop the most though is friendship. His nature has a tendancy to weird people out sometimes but people are often charmed by his candid way of thinking about trivial things for them.

Seeking for advice and frienship

When he doesn't grab a concept or he is enable to determine the good course of action, he often goes to his friends for help.

What I like in TNG is how patient everyone is and ready to give their best to help one another. It gives some nice discussion, on sometimes tough subjects.

To be fair, Data becomes friend with a lot of people and people around him adjust to his lack of emotions pretty well as they usually find his ways enough to empathise with him.

Each of his friend is very different or course and will give him different perspective on his problems.

From the relationships I like the most : Geordy is the bro, Picard a more father like figure, and Worf is more of the direct approach - no feelings gets in the way. Then, we have Deanna Troi and Guinan who are for me the two sides of the same coin for him.

Geordy and Worf

I put them together because with Data they share a common ground for my analysis : they have difficulties in their love affairs. Data we saw why just before. Geordy is married to his job and has difficulties to link with women. Worf is culturally different from the vast majority and it will take time for him to open up to interracial lovers.

For me, those two are his best pals, in the common sense. Geordy is the definition of his ultimate friend. They go through a lot together. He is openly friendly and emotional towards Data. And Data will help him in some difficult moment, showing trust when no-one does.

Worf is very different and their friendship is more in the Klingons ways. They have frictions sometimes but a huge respect for each other. And they can tell the truth bluntly when need be. There is no hiding things.

Although Data can be really random with him sometimes trying to experiment human relationships with him, and hilarity ensures 😅.

The case Picard

This is one of the most touching for me, because Picard has a real problem with children, but Data grows like the son he never had. They are friends but there is that profound link that build up with time. Data is loyal to Picard to great extend and vice versa. And there is that sacrifice tendency Kirk and Spock had, that link them.

The case Deanna Troi and Guinan

They are the neutral counselor in a way. They are not friend with Data the same way of a Geordy or a Picard but there is a connection. Data values their point of view and advices. And they both like him a lot.

Deanna is the kind of the opposite of Data in a way and their connection is slow but really rewarding to me.

I had some difficulties with her character during the series because the stories around her were often turned into weird kinks and sometimes disturbing subjects, that she recovers from too easily. But her character often help to show a different side of peoples, as she is the ship counsellor and sort of psychologist. From her race, she has empathic abilities that she uses to feel people emotions.

But with Data, there is nothing to read, yet he will ask her help to define some emotions from his camarades he is confused by, how to respond to it, what is the correct way of action. And she will push him to explore more abstract concepts.

I liked their time together because, at first, she was a bit guarded with him because as he has no emotions she can't read him, but she became one of the most invested in his emotional quest, and grew emotionally attached to him.

Guinan is an enigmatic character but she often has the insight that helps people when they need. Data values her judgement and will come sometimes for advices. She is good sport with him and participate in some of his experience, like trying to understand humour.

She is mostly helping people in their line of thoughts, digging a bit what they want and need to help them figure out the rest.

And this is what she does about is first love affair.

Conclusion :

I wrote way more than I intended lool. I love Data for his quest of humanity, helping decipher things on the way. And I recognise myself in a lot of his behaviour around love, thriving more in casual relationships and friendships than finding anything for more in love affairs. And the character delivers so many nuances that highlight the complexity of human relations and emotions.

[best-testing-lab-uae]

How Virology Testing Labs in Abu Dhabi Help Pharmaceutical Companies with Clinical Trials? | +971 554747210

Pharmaceutical companies are at the forefront of medical innovation, developing new drugs and vaccines that save lives worldwide. Clinical trials, a critical phase in this development process, require precise and reliable virology testing to ensure safety, efficacy, and regulatory compliance. In Abu Dhabi, virology testing labs have become vital partners for pharmaceutical companies engaged in clinical trials, providing advanced testing services that meet global standards.

This blog explores how virology testing lab in Abu Dhabi support pharmaceutical companies during clinical trials, highlighting their key roles, services, and benefits.

The Importance of Virology Testing in Clinical Trials

Clinical trials are rigorous research studies conducted to evaluate new medical products in human subjects. When these products involve viral infections, vaccines, or antiviral drugs, virology testing is crucial to:

Detect and quantify viral presence in patient samples.

Monitor viral load changes throughout the trial.

Assess immune responses to investigational products.

Ensure participant safety by early identification of viral infections or reactivations.

Generate robust data for regulatory submissions.

Given these demands, pharmaceutical companies rely heavily on specialized virology testing labs with the expertise and infrastructure to deliver accurate, reproducible, and timely results.

Why Pharmaceutical Companies Choose Virology Testing Labs in Abu Dhabi

Abu Dhabi offers several advantages that make it a preferred hub for pharmaceutical virology testing:

State-of-the-art laboratories: Equipped with cutting-edge technologies such as Real-Time PCR, Next-Generation Sequencing (NGS), and serological assays.

Accreditation and compliance: Labs meet international quality standards, including ISO 15189 and GCLP (Good Clinical Laboratory Practice), ensuring data integrity and regulatory acceptance.

Experienced virologists and technicians: Skilled personnel understand the nuances of clinical trial testing and complex viral diagnostics.

Strategic location: Abu Dhabi serves as a gateway between East and West, facilitating international collaboration and faster sample logistics.

Regulatory support: Local labs work closely with UAE health authorities, streamlining approvals and compliance with global regulatory bodies like FDA, EMA, and WHO.

Key Services Offered by Virology Testing Labs for Clinical Trials

1. Molecular Testing for Viral Detection and Quantification

Molecular assays, primarily Real-Time PCR (RT-PCR), are the gold standard in virology testing during clinical trials. They enable:

Sensitive detection of viral nucleic acids in biological samples (blood, swabs, tissues).

Quantification of viral load, essential for evaluating antiviral drug efficacy or vaccine impact.

Genotyping and mutation analysis to track viral variants or resistance markers.

Abu Dhabi virology labs utilize validated PCR platforms with strict quality control to ensure consistent performance throughout trial phases.

2. Serological Testing for Immune Response Assessment

Serology tests detect antibodies (IgM, IgG) produced in response to viral infections or vaccination. These tests help pharmaceutical companies to:

Determine baseline immunity of trial participants.

Monitor seroconversion and antibody titers post-vaccination or treatment.

Evaluate durability of immune responses over time.

Labs in Abu Dhabi offer ELISA, chemiluminescence, and neutralization assays tailored to the specific virus and trial design.

3. Viral Culture and Phenotypic Analysis

While less common, viral culture remains important in some clinical trials for isolating live virus and studying phenotypic characteristics, including:

Susceptibility to investigational antiviral agents.

Viral replication kinetics.

Specialized virology labs in Abu Dhabi maintain biosafety level 2 and 3 facilities needed for safe culture and handling of infectious agents.

4. Next-Generation Sequencing (NGS)

NGS technologies are increasingly used in clinical trials to:

Deeply characterize viral genomes.

Identify emerging mutations and variants that may impact treatment outcomes.

Support personalized medicine approaches.

Abu Dhabi labs provide comprehensive NGS services with rapid data analysis and reporting capabilities.

Ensuring Quality and Compliance in Clinical Trial Testing

Pharmaceutical companies must comply with stringent regulatory requirements when conducting clinical trials. Virology testing labs in Abu Dhabi support this by:

Following Good Clinical Laboratory Practice (GCLP) guidelines ensuring laboratory processes meet trial protocols.

Implementing ISO 15189 accreditation, guaranteeing quality management systems and technical competence.

Maintaining strict chain of custody and sample tracking to ensure data integrity.

Providing audit support and documentation for sponsors and regulatory agencies.

Participating in external quality assessment (EQA) programs to benchmark performance.

These practices help pharmaceutical companies produce reliable data that regulators worldwide trust.

Collaborative Role in Trial Design and Protocol Development

Beyond testing, many virology labs in Abu Dhabi collaborate with pharmaceutical sponsors during the clinical trial planning phase by:

Advising on sample collection methods and timing to optimize viral detection and immune response assessment.

Designing customized testing panels aligned with trial endpoints.

Assisting with statistical planning for virology data analysis.

Ensuring compliance with local and international biosafety regulations.

Such partnerships enhance trial efficiency and data quality.

Rapid Turnaround Times for Timely Decision-Making

Clinical trials operate on tight schedules, and timely virology results are essential for:

Monitoring participant safety in real-time.

Making go/no-go decisions on trial progression.

Supporting interim analyses for regulatory reporting.

Virology testing labs in Abu Dhabi are equipped with automation and workflow optimization to deliver fast turnaround times—often within 24 to 48 hours for molecular assays—without compromising accuracy.

Case Study: Supporting COVID-19 Vaccine Trials in Abu Dhabi

The COVID-19 pandemic underscored the critical role of virology testing labs in clinical trials. Abu Dhabi’s labs swiftly adapted to meet the demand for:

Large-scale RT-PCR testing to monitor viral load in vaccine recipients.

Serological assays to measure antibody responses post-vaccination.

Variant analysis via NGS to track emerging strains affecting vaccine efficacy.

Pharmaceutical companies developing COVID-19 vaccines leveraged these capabilities to accelerate trial phases and achieve rapid regulatory approvals.

Cost-Effectiveness and Local Expertise

Partnering with local virology testing labs in Abu Dhabi reduces logistical costs associated with international shipping and customs delays. Additionally, local expertise helps navigate UAE-specific regulatory and cultural considerations, resulting in smoother trial operations.

Conclusion

Virology testing labs in Abu Dhabi are indispensable allies for pharmaceutical companies conducting clinical trials involving viral pathogens. Their advanced technologies, adherence to international quality standards, expert personnel, and collaborative approach help ensure that clinical trial data is accurate, timely, and regulatory-compliant.

By choosing a reputable virology testing lab in Abu Dhabi, pharmaceutical companies benefit from streamlined workflows, reliable viral diagnostics, and invaluable scientific support, ultimately contributing to the successful development of innovative medicines and vaccines that improve global health.

[bisresearch0]

Latin America NGS Market - Analysis and Forecast, 2024-2034 

The Latin America next-generation sequencing (NGS) market refers to the comprehensive application of NGS technologies for clinical diagnostics, translational research across Latin American countries. This market includes instruments, such as sequencers, and consumables, such as reagents, kits, software, and services. 

Next-generation sequencing (NGS) is transforming healthcare by enabling comprehensive genomic analysis for personalized medicine. NGS facilitates the use of targeted medicines, accurate tumor profiling, and the discovery of actionable mutations in oncology. Through the use of circulating tumor DNA, it enables non-invasive cancer surveillance in liquid biopsies. Rapid pathogen identification and non-invasive prenatal diagnostics also depend on NGS. The use of NGS is accelerating in Latin America due to the increased rates of genetic diseases and cancer. With the help of public-private partnerships, nations like Brazil and Mexico are making investments in precision medicine and genomic testing. The Latin American NGS industry is expected to grow significantly as clinical laboratories use NGS into diagnosis and research collaborations increase.

In 2024, The Latin America NGS Market was valued at $268.04 million. It is projected to grow at a compound annual growth rate (CAGR) of 8.34%, reaching $597.20 million by 2034.

Key Emerging Trends

Growing Interest in Personalized Medicine: NGS is being widely used in the region for research on infectious diseases and cancer, especially for precision diagnostics. NGS is essential for virology and mutation detection, including in illnesses like COVID-19.

Developing Local Infrastructure: Countries in Latin America are making investments to build up their own genomics talent and infrastructure. To lessen reliance on foreign platforms, initiatives such as Mexico's CABANA model are assisting in the construction of genomic centers and bioinformatics training.

Improved Accessibility of Genomic Data: Localized genetic data is becoming more accessible because to cooperative initiatives in nations like Mexico and Brazil. In order to promote more equitable and accurate research outputs for local communities, companies like as Lifebit, Omica.bio, and gen-t are assisting in ensuring greater representation in global datasets.

Market Segmentation

By Offering

Instruments

Kits and Consumables

Software

Services

By Technology

Ion Torrent Semiconductor Sequencing

Reversible Terminator Sequencing (SBS)

Single Molecule Real-Time Sequencing

Nanopore Sequencing Technologies

By Application

Clinical

Translational Research

By End User

Hospitals and Clinics

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Government Labs

Major Market Challenges

High Costs: The high cost of NGS testing is still a major obstacle in Latin America, particularly in lower-income countries like Brazil, Mexico, and Argentina, even if prices are declining globally. Wider integration into national healthcare systems is hampered by this.

Inadequate Finances and Compensation: Investments in genetic testing infrastructure are constrained by public healthcare institutions' limited financial resources. As a result, clinical adoption is further hampered by poor reimbursement rates and continued reliance on pricey private laboratories.

Professional and Educational Gaps: Patients and healthcare professionals are notably unaware about the potential and advantages of genetic technologies. Widespread adoption in nations like Brazil is also further delayed by a lack of qualified personnel and ambiguous clinical recommendations.

Get Informed: Explore the Influence of Increasing Investments in The Latin America NGS Market Market – Access Our Sample Report!

Learn more about Healthcare Vertical. Click Here!

Conclusion

The growing desire for customized treatment, improved local infrastructure, and growing collaborations in genomic research are driving the Latin American NGS market's encouraging growth trajectory. Even if there are still issues like high expenses, a lack of funding, and a lack of workers, continued investments and clever partnerships are opening the door for wider usage.

Over the next ten years, Latin America is anticipated to emerge as a major force in the global healthcare genomics arena thanks to enhanced accessibility, greater educational opportunities, and the development of regional genomic capabilities.

[swati3191]

A Day in the Life at Greenarray Genomics: Behind the Scenes at a Cutting-Edge Lab

Genetic testing may begin with a sample and end with a report, but between those two points lies an entire world of science, precision, and passion. At Greenarray Genomics Research and Solutions Pvt. Ltd., each day is a dynamic journey through the intricate layers of molecular diagnostics, cytogenetics, and clinical research.

Step inside our state-of-the-art lab in Pune and experience what a typical day looks like behind the scenes — where genetic data meets human dedication.

☀️ 8:30 AM – Starting with Sterility and Structure

The day begins with our team of lab technologists, molecular biologists, and cytogeneticists suiting up in sterile gear — coats, gloves, caps. First up is equipment calibration and quality checks, ensuring every sequencer, incubator, and PCR machine is operating at peak precision.

“Clean environment and equipment validation come first. In genetics, even the smallest contaminant can skew results.” — Shruti, Senior Lab Technician

🧪 9:30 AM – Sample Arrival and Registration

Samples from hospitals, clinics, and direct clients start arriving — amniotic fluid for prenatal testing, blood samples for thalassemia screening, buccal swabs for hereditary cancer panels, and more.

Our accessioning team registers each sample, assigning it a unique barcode and logging it into the Laboratory Information Management System (LIMS). Every sample’s journey is now traceable — from extraction to analysis.

🔬 10:00 AM – DNA Extraction & Cytogenetic Culturing

In two different wings of the lab, parallel activities unfold:

In the molecular lab, DNA is being extracted using automated platforms to ensure high-quality yield — the starting point for accurate genetic analysis.

In the culture center, fetal and tumor cells are gently nurtured in incubators. Our cytogenetics team monitors cell growth, preparing slides for karyotyping and FISH (Fluorescence In Situ Hybridization) analysis.

“Each cell culture has its personality — some grow fast, some need extra care. We’re patient, because the diagnosis depends on it.” — Dr. Prajakta, Cytogenetics Head

🧬 12:00 PM – NGS Prep and Sequencing Runs

It’s time for Next Generation Sequencing (NGS). Our bioinformaticians and molecular technologists prepare DNA libraries for sequencing. Samples are placed into high-throughput sequencers, which begin decoding millions of DNA fragments in parallel.

Real-time monitoring ensures data quality, while controls and replicates validate every run.

💻 3:00 PM – Bioinformatics & Data Analysis

Once sequencing is complete, terabytes of raw data flow into our bioinformatics servers. Now the digital detectives take over — aligning sequences, identifying mutations, and filtering out false positives using AI-assisted pipelines.

Reports are generated, reviewed by geneticists, and interpreted in a clinical context. Is this BRCA mutation pathogenic? Could this CNV explain a child’s developmental delay? These are questions we answer with science and sensitivity.

📞 5:00 PM – Reporting & Genetic Counseling

Reports are dispatched to clinicians, hospitals, and patients, often accompanied by genetic counseling sessions. We take time to explain the meaning behind every variant — whether it’s actionable, inherited, or of uncertain significance.

“We don’t just give test results. We help people understand their health, their families, and their future.” — Dr. Sanjay Gupte, Founder & Director

🌙 6:30 PM – Winding Down, Preparing for Tomorrow

As the lab winds down, teams clean and sterilize workspaces, back up data, and prepare for the next batch of samples. Quality assurance teams review logs, ensuring every protocol was followed — because consistency builds trust.

🚀 More Than a Lab — A Mission

At Greenarray Genomics, we don’t just perform tests — we solve puzzles, enable prevention, and empower care. Every day here is a reminder that behind every tube is a story, a family, a decision that matters.

So whether we’re decoding rare disorders, aiding prenatal care, or supporting cancer treatment, our mission remains clear: Deliver accurate, timely, and compassionate genetic insights — with integrity and innovation.

[bjmadan12]

BJ Madan: Empowering Precision Oncology Companies in India with Trusted Supply Solutions

BJ Madan – A Trusted Partner to India’s Leading Precision Oncology Companies

Cancer treatment is undergoing a paradigm shift, moving from conventional therapies to precision oncology—an approach that tailors treatment based on a patient's unique genetic and molecular profile. This targeted, data-driven method is helping doctors choose the most effective therapies with fewer side effects and better outcomes. As precision oncology companies across India lead this transformation, BJ Madan & Co. stands as a reliable partner, delivering the critical supplies and solutions needed to make personalized cancer care a reality.

 

What is Precision Oncology?

Precision oncology combines cutting-edge diagnostics such as:

Next-generation sequencing (NGS)

Molecular profiling

Biomarker detection

Companion diagnostics

to create individualized treatment strategies for patients. This evolution demands not only innovation but also a dependable supply chain for specialized equipment, reagents, and consumables.

 

BJ Madan: A Backbone for Precision Oncology Infrastructure

With over six decades of experience in healthcare supply, BJ Madan plays a vital role in enabling cancer care innovators by supplying:

High-quality radiopharmaceuticals and PET imaging agents

Molecular diagnostics kits and reagents

Sterile consumables for genetic and tissue analysis

Radiation shielding and lab safety products

cGMP-compliant products for clinical research and trials

 

Why Precision Oncology Companies Trust BJ Madan

Unmatched Experience: A legacy of supplying top-tier hospitals, research labs, and pharma companies

Global Network: Strong partnerships with certified international and Indian manufacturers

Compliance Ready: Products meet all major regulatory and clinical standards

Custom Solutions: Sourcing flexibility to meet the unique needs of oncology labs and startups

 

Enabling India’s Shift to Personalized Cancer Care

As precision oncology becomes the standard of care, BJ Madan is proud to support this transformation. Whether it’s a biotech startup developing targeted therapies or a cancer center expanding its diagnostic capabilities, BJ Madan ensures that innovation never stops due to supply gaps.

BJ Madan – Supplying the Future of Cancer Treatment, Precisely.

Let me know if you’d like this turned into a short LinkedIn post, brochure copy, or SEO blog for a website.

Visit:- https://www.bjmadan.com/precision-oncology.html

[pathologylab]

Genetics is the new frontier of healthcare, and #Genes2Me is your one-stop solution for next generation sequencing tools. We provide a whole range of focused 27+ CE-IVD marked #NGS Clinical Panels compatible with #Illumina, Thermofisher and MGI platforms. The panels are designed for accurate #diagnosis of a variety of #genetic and somatic #cancers, cardiovascular, respiratory and neurological disorders which aid in the prevention as well as timely treatment of the patient. Our NGS clinical #panels are complemented with cloud-based automated data analysis #software called #CliSeq Interpreter.

#nextgenerationsequencing #bioinformatics #genomics #ngspanels #analysis #sequencing #research #liquidbiopsy #ngsanalysis #genomics #biotech #biotechnology #bioinformatics #yearsofexcellence #data #bioindia #dna #rna #liquidbiopsy #sequencing #genome #genomeanalysis #molecularbiology #g2m

[forbiddenhoardtreasure]

Global Metagenomic Sequencing Market is driven by Technological Advances

Metagenomic sequencing platforms enable comprehensive analysis of genetic material directly from environmental or clinical samples, bypassing the need for traditional culturing methods. These products include high-throughput DNA sequencers, library preparation kits, and bioinformatics software tailored for microbiome profiling, pathogen detection, and biodiversity assessment. Advantages such as unbiased community profiling, rapid turnaround times, and scalable workflows make metagenomic sequencing indispensable for research institutions, pharmaceutical developers, and diagnostic laboratories. The ability to detect novel organisms and antimicrobial resistance genes directly influences drug discovery, public health surveillance, and agricultural biosecurity initiatives. Growing concerns over emerging infectious diseases and the quest for precision medicine have intensified the need for Global Metagenomic Sequencing Market­­­, driving investments in improved sample prep and cloud-based analytics. Ongoing market research into enhanced read lengths and error correction methods further bolsters confidence in metagenomic data for regulatory submissions. As sequencing costs decline and data interpretation tools mature, adoption is expanding across clinical and environmental applications, reshaping the industry’s market dynamics and enabling businesses to capture greater market share. Global metagenomic sequencing market size is expected to reach US$ 6.16 Bn by 2032, from US$ 1.96 Bn in 2025, exhibiting a compound annual growth rate (CAGR) of 17.8% during the forecast period.Key Takeaways Key players operating in the Global Metagenomic Sequencing Market are: -Illumina-QIAGEN-Thermo Fisher Scientific-Oxford Nanopore Technologies-BGI GroupThese market players leverage robust R&D pipelines to introduce next-generation sequencing instruments, advanced sample prep solutions, and AI-driven analysis software. Illumina’s NovaSeq series, QIAGEN’s QIAseq kits, Thermo Fisher’s Ion Torrent systems, Oxford Nanopore’s MinION platform, and BGI Group’s DNBSEQ instruments exemplify the competitive landscape. Through strategic collaborations, acquisitions, and co-development agreements, these companies aim to extend their product portfolios and strengthen service offerings. Their efforts are guided by comprehensive market research and detailed market reports, ensuring that portfolio expansions align with evolving customer demands and regulatory requirements. Continuous innovation in sequencing chemistries and data compression algorithms supports sustained revenue growth and reinforces their leading positions in the global industry.Rising awareness of the human microbiome’s role in health and disease is driving strong demand for metagenomic sequencing services. Healthcare providers and researchers seek detailed microbial profiles to inform personalized treatment plans, monitor therapeutic interventions, and detect pathogens in real time. Similarly, agricultural and environmental sectors adopt metagenomic workflows to optimize crop yields, assess soil health, and track pollutant-degrading bacteria. The convergence of big data analytics with advanced sample processing has unlocked new market opportunities across pharmaceuticals, diagnostics, and ecology. Growing investments in microbiome-based therapeutics and probiotic formulations further ignite demand.

‣ Get More Insights On: Global Metagenomic Sequencing Market­­­

‣ Get this Report in Japanese Language: 世界のメタゲノムシーケンシング市場

‣ Get this Report in Korean Language: 글로벌메타게놈시퀀싱시장

‣ Resources- Global Metagenomic Sequencing: Unlocking the Secrets of Microbial Communities

[shpl-india]

Precision Medicine in Nephrology: Personalized Treatment Protocols for Optimal Kidney Care

The field of nephrology is rapidly advancing through the adoption of Precision Medicine in Nephrology, which tailors treatment protocols to individual patient characteristics. This personalized approach leverages genetic and molecular insights alongside advanced treatment methodologies to improve outcomes and minimize adverse effects. This article explores the transformative potential of precision medicine in kidney care.

Individualized Care Strategies in Nephrology

Precision medicine moves beyond the one-size-fits-all model, focusing on identifying patient-specific factors such as genetics, lifestyle, and environmental exposures. This enables nephrologists to design targeted treatment plans that address the unique causes and progression patterns of kidney disease in each individual. Key elements include:

Comprehensive patient profiling using clinical, genetic, and biochemical data.

Customized medication regimens to maximize efficacy and reduce side effects.

Dynamic treatment adjustments based on ongoing patient response.

Individualized care strategies improve disease control and enhance patient quality of life by ensuring interventions are as effective and safe as possible.

Genetic and Molecular Approaches Driving Precision Medicine

Breakthroughs in genomic and molecular science have revolutionized nephrology. Genetic testing helps identify inherited kidney disorders and susceptibility to diseases such as polycystic kidney disease, focal segmental glomerulosclerosis, and more. Molecular biomarkers provide insights into disease mechanisms, enabling:

Early diagnosis even before symptoms appear.

Prediction of disease progression and treatment response.

Identification of novel therapeutic targets for drug development.

Integration of these approaches facilitates informed decision-making and paves the way for innovative therapies tailored to molecular profiles.

Advanced Treatment Methodologies Supporting Personalized Care

Advanced technologies are essential to implementing precision medicine effectively in nephrology. These include:

Next-Generation Sequencing (NGS): For detailed genetic analysis.

Artificial Intelligence (AI): To analyze complex datasets, recognize patterns, and predict outcomes.

Targeted Drug Therapies: Designed to interact with specific molecular pathways involved in kidney disease.

Telemedicine Platforms: Enabling continuous monitoring and personalized adjustments in treatment remotely.

Combining these methodologies offers a comprehensive toolkit for delivering precise, patient-centered kidney care.

Benefits of Embracing Precision Medicine in Nephrology

Implementing Precision Medicine in Nephrology translates into several concrete benefits, including:

Enhanced diagnostic accuracy and early intervention.

Reduced trial-and-error prescribing, minimizing adverse drug reactions.

Improved management of complex and rare kidney disorders.

Empowerment of patients through personalized care plans.

Advancement of nephrology research leading to new therapies.

Final Thoughts

Precision Medicine in Nephrology represents a paradigm shift in kidney care, harnessing the power of genetics, molecular biology, and technology to tailor treatments uniquely suited to each patient. By adopting personalized treatment protocols, nephrologists can offer more effective, safer, and patient-focused care, ultimately improving long-term kidney health outcomes.

[heriditybio]

Biotechnology Training Programs in Bhubaneswar: A Comprehensive Guide

Biotechnology is a rapidly evolving field that combines biology, chemistry, and technology to develop innovative solutions in healthcare, agriculture, and environmental sustainability. With increasing demand for skilled professionals, biotechnology training programs have become essential for students and professionals looking to advance their careers.

Bhubaneswar, the capital city of Odisha, has emerged as a hub for biotechnology education and research. Several institutes and organizations offer specialized training programs, equipping learners with hands-on experience and industry-relevant skills. Among these, Heredity Biosciences stands out as a leading provider of biotechnology training and summer internships in Bhubaneswar.

This article provides a detailed analysis of biotechnology training programs in Bhubaneswar, covering key institutions, course structures, career prospects, and the role of Heredity Biosciences in shaping the future of biotechnology professionals.

The Growing Importance of Biotechnology Training

Biotechnology is a multidisciplinary field with applications in:

Healthcare (drug development, genetic engineering, diagnostics)

Agriculture (GM crops, biofertilizers)

Industrial Biotechnology (enzyme production, biofuels)

Environmental Biotechnology (waste management, bioremediation)

According to a report by IBEF (India Brand Equity Foundation), the Indian biotechnology industry is expected to reach $150 billion by 2025, creating a surge in demand for trained professionals. Odisha, with its focus on education and research, is positioning itself as a key player in this sector.

Why Choose Bhubaneswar for Biotechnology Training?

Presence of reputed universities and research institutes

Growing biotech startups and industrial collaborations

Government initiatives promoting skill development in life sciences

Top Biotechnology Training Programs in Bhubaneswar

Several institutions in Bhubaneswar offer biotechnology training, ranging from short-term courses to advanced diplomas. Below is an overview of the key programs available:

1. Heredity Biosciences

Established: 2021 Specializations: Molecular Biology, Genetic Engineering, Clinical Research, Bioinformatics

Heredity Biosciences is a trusted provider of research and training services to hospitals, life sciences institutes, and pharmaceutical companies. Their programs are designed by experienced scientists and industry professionals, ensuring practical and industry-aligned training.

Key Offerings:

Biotechnology Summer Internships in Bhubaneswar – Hands-on training in lab techniques, data analysis, and research methodologies.

Specialized Certification Courses – Covers PCR, Gel Electrophoresis, CRISPR, and Next-Generation Sequencing (NGS).

Industry Collaborations – Partnerships with pharmaceutical and healthcare organizations for real-world exposure.

Why Choose Heredity Biosciences?

Expert-led training with professionals from life sciences and healthcare industries.

State-of-the-art lab facilities for practical learning.

Placement assistance for internships and jobs in biotech firms.

2. Institute of Life Sciences (ILS), Bhubaneswar

Offers PhD programs, internships, and workshops in biotechnology.

Focus areas: Cancer Biology, Infectious Diseases, Plant Biotechnology.

Collaborates with CSIR, DBT, and ICMR for research projects.

3. KIIT University – School of Biotechnology

B.Tech, M.Tech, and PhD programs in Biotechnology.

Industry-oriented curriculum with internships at leading biotech companies.

4. Centurion University – Department of Biotechnology

Offers B.Sc, M.Sc, and Diploma courses in Biotechnology.

Skill-based training in fermentation technology, bioinformatics, and genetic engineering.

5. SOA University – Department of Biotechnology

Integrated M.Sc in Biotechnology with research-focused training.

Collaborations with biotech industries for student placements.

Career Prospects After Biotechnology Training

Completing a biotechnology training program in Bhubaneswar opens doors to various career opportunities, including:

1. Research & Development (R&D)

Roles: Research Scientist, Lab Technician, Bioinformatics Analyst

Employers: Pharmaceutical companies, research labs, universities

2. Healthcare & Clinical Research

Roles: Clinical Research Associate, Medical Writer, Genetic Counselor

Employers: Hospitals, diagnostic centers, CROs (Contract Research Organizations)

3. Agricultural Biotechnology

Roles: Agricultural Scientist, Bioprocess Engineer

Employers: Agri-biotech firms, seed companies, government research bodies

4. Industrial & Environmental Biotechnology

Roles: Quality Control Analyst, Environmental Consultant

Employers: Biotech industries, environmental agencies

Salary Expectations

Entry-level positions: ₹3-5 LPA

Mid-level scientists: ₹6-10 LPA

Senior researchers/PhDs: ₹12-20 LPA+

(Source: Naukri.com, Glassdoor India)

Why Biotechnology Summer Internships Matter

Internships provide hands-on experience, industry exposure, and networking opportunities. Heredity Biosciences offers summer internships in Bhubaneswar, allowing students to:

Work on real research projects under expert guidance.

Learn advanced techniques like PCR, ELISA, and DNA sequencing.

Gain certification to enhance employability.

Success Stories

A student from Ravenshaw University secured a research position at a leading biotech firm after completing an internship at Heredity Biosciences.

A KIIT biotechnology graduate credited their industry readiness to hands-on training received during a summer internship.

Government and Industry Support for Biotechnology in Odisha

The Odisha government and central agencies are actively promoting biotechnology through:

Biotech Policy 2021 – Incentives for biotech startups and skill development.

DBT (Department of Biotechnology) funding for research projects.

Collaborations with institutes like ILS and IIT Bhubaneswar.

Conclusion: Choosing the Right Biotechnology Training Program

Bhubaneswar offers diverse biotechnology training programs, catering to students and professionals at different career stages. Heredity Biosciences stands out for its industry-aligned courses, expert faculty, and internship opportunities, making it a top choice for aspiring biotechnologists.

Whether you are a student seeking hands-on training or a professional looking to upskill, enrolling in a biotechnology program in Bhubaneswar can be a game-changer for your career.

Key Takeaways:

For those looking to kickstart their biotechnology career, enrolling in a training program or summer internship in Bhubaneswar is a strategic move toward success.

[best-testing-lab-uae]

Exploring Advanced Microbiological Testing Techniques Used by Labs in Abu Dhabi | +971 554747210

In today’s fast-evolving landscape of health, environment, and industry, microbiological testing plays a pivotal role in ensuring the safety and quality of products and environments. From food and pharmaceuticals to water and cosmetics, detecting and controlling microbial contamination is critical. In Abu Dhabi, the capital of the UAE and a hub for innovation and stringent regulatory standards, microbiological testing lab employ advanced techniques to meet growing demands for accuracy, speed, and reliability.

This blog explores the cutting-edge microbiological testing techniques used by laboratories in Abu Dhabi, highlighting how these advancements enhance detection capabilities, support regulatory compliance, and safeguard public health.

The Growing Importance of Microbiological Testing Labs in Abu Dhabi

Abu Dhabi’s rapid development across sectors such as healthcare, food processing, pharmaceuticals, water management, and cosmetics drives the need for rigorous microbiological testing. The UAE government enforces strict standards through agencies like the Abu Dhabi Quality and Conformity Council (QCC), Department of Health – Abu Dhabi (DOH), and Environment Agency – Abu Dhabi (EAD), requiring labs to maintain exceptional precision.

Microbiological testing labs in Abu Dhabi are therefore adopting state-of-the-art techniques that go beyond traditional methods to provide comprehensive microbial analysis for bacteria, fungi, viruses, and other microorganisms.

Traditional vs. Advanced Microbiological Testing Techniques

Traditional microbiological methods like culture-based techniques and microscopic examinations have been the backbone of microbial detection. However, they are often time-consuming, labor-intensive, and sometimes lack sensitivity.

Advanced techniques now complement or replace these older methods, offering:

Faster results

Higher sensitivity and specificity

Ability to detect non-culturable or slow-growing organisms

Quantitative data for better risk assessment

Let’s dive into some of the most prominent advanced microbiological testing techniques used by Abu Dhabi labs.

Key Advanced Microbiological Testing Techniques Used in Abu Dhabi

1. Polymerase Chain Reaction (PCR) and Real-Time PCR (qPCR)

PCR is a molecular biology technique that amplifies specific DNA sequences, allowing labs to detect even tiny amounts of microbial DNA in samples. Real-Time PCR (qPCR) adds quantitative capabilities, measuring the amount of DNA in real time.

Benefits: Rapid detection (within hours), high sensitivity, ability to detect viable but non-culturable organisms.

Applications: Foodborne pathogen detection, pharmaceutical sterility testing, water quality analysis, and clinical diagnostics.

In Abu Dhabi, PCR and qPCR are widely used to screen for pathogens such as Salmonella, Listeria monocytogenes, E. coli, and Legionella.

2. Next-Generation Sequencing (NGS)

NGS offers comprehensive analysis by sequencing entire microbial genomes or microbial communities (metagenomics). It helps identify bacteria, viruses, fungi, and other microorganisms present in complex samples.

Benefits: Unbiased detection of all microbes, discovery of novel pathogens, tracking antimicrobial resistance genes.

Applications: Environmental monitoring, outbreak investigation, microbiome studies.

Some Abu Dhabi labs are integrating NGS to advance research and diagnostic precision, especially in pharmaceutical and environmental sectors.

3. Flow Cytometry

Flow cytometry uses lasers and fluorescent dyes to rapidly count and characterize microorganisms in a liquid sample based on size, granularity, and fluorescence.

Benefits: Fast enumeration of live/dead cells, multiparametric analysis.

Applications: Water quality testing, pharmaceutical contamination control, bioprocess monitoring.

This technique enhances routine monitoring and quality control processes in Abu Dhabi industries.

4. Automated Microbial Identification Systems

Technologies like MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight) mass spectrometry allow rapid and accurate identification of microbial species by analyzing protein patterns.

Benefits: Identification in minutes, high accuracy, reduced manual labor.

Applications: Clinical microbiology, food safety labs, pharmaceutical testing.

Abu Dhabi labs employ these systems to streamline microbial identification and improve turnaround times.

5. Biosensors and Rapid Detection Kits

Biosensors combine biological components with electronic systems to detect microbes through antigen-antibody interactions or nucleic acid hybridization. Rapid kits offer point-of-care or on-site testing capabilities.

Benefits: Real-time monitoring, user-friendly, portable.

Applications: Food safety inspections, environmental surveillance, clinical testing.

These emerging technologies complement traditional lab testing and are gaining traction in Abu Dhabi’s food and healthcare sectors.

How Abu Dhabi’s Microbiological Testing Labs Leverage Advanced Techniques

Enhancing Public Health Safety

Microbiological testing labs in Abu Dhabi play a crucial role in protecting public health by providing rapid and reliable pathogen detection. Advanced methods reduce the time to identify contamination sources in food, water, and pharmaceuticals, enabling quick responses to prevent disease outbreaks.

Supporting Regulatory Compliance

Stringent regulations require accurate microbial testing to certify products and environments. Advanced technologies ensure compliance with UAE standards, GCC regulations, and international bodies like ISO, FDA, and WHO.

Improving Product Quality and Shelf Life

Food manufacturers, cosmetic companies, and pharmaceutical firms depend on microbiological labs to assess contamination risks. Techniques like qPCR and MALDI-TOF help detect spoilage organisms early, ensuring product safety and extending shelf life.

Facilitating Research and Innovation

NGS and other high-throughput techniques empower research institutions and companies in Abu Dhabi to explore microbial ecosystems, discover novel probiotics, or study antimicrobial resistance, driving innovation.

Choosing the Right Microbiological Testing Lab in Abu Dhabi

To benefit from advanced microbiological testing, businesses and regulators must select labs that offer:

ISO/IEC 17025 Accreditation: Ensures technical competence and consistent quality.

State-of-the-Art Equipment: Access to PCR machines, NGS sequencers, MALDI-TOF, flow cytometers.

Experienced Staff: Skilled microbiologists and molecular biologists.

Comprehensive Services: From routine screening to specialized research testing.

Fast Turnaround: Critical for time-sensitive products and regulatory approvals.

Strong Regulatory Knowledge: Familiarity with UAE and GCC standards.

Conclusion

Microbiological testing labs in Abu Dhabi have embraced a range of advanced techniques that revolutionize microbial detection and identification. By combining molecular methods like PCR and NGS with technologies such as flow cytometry and MALDI-TOF, these labs provide unparalleled accuracy, speed, and depth of analysis. This not only supports regulatory compliance and public health but also boosts product quality and innovation across sectors.

For companies operating in food, pharmaceuticals, cosmetics, or environmental management in Abu Dhabi, partnering with a cutting-edge microbiological testing lab is essential to meet the highest standards of safety and quality in today’s competitive market.